**Flibanserin CAS NO.167933-07-5
- FOB Price: USD: 1.00-1.00 /Gram Get Latest Price
- Min.Order: 10 Gram
- Payment Terms: T/T,MoneyGram,Other
- Available Specifications:
1(1-100)Gram1(1-100)Gram
- Product Details
Keywords
- 167933-07-5
- Flibanserin
- C20H21F3N4O
Quick Details
- ProName: **Flibanserin
- CasNo: 167933-07-5
- Molecular Formula: C20H21F3N4O
- Appearance: white crystal
- Application: research
- DeliveryTime: 3days
- PackAge: silver bags
- Port: tianjin;shanghai;qingdao
- ProductionCapacity: 20 Metric Ton/Month
- Purity: 99%
- Storage: dry
- Transportation: Mode of Transportation: By air or ship...
- LimitNum: 10 Gram
- Residue on Ignition: 1
- Valid Period: 2040
- state: powder
- cas no: 167933-07-5
Superiority
1.How is the quality
The qualities of most products are above 99% purity,same are 99.5% purity.
2.How is the package
Foil bag or as customer's required.
3.How is the storage
Pls keep dry and cool place.
4.Do I need to pay extra for shipping cost
No,our price includes the shipping cost already,you need not pay for any tax and others.
5.Can I order sample for testing
Of course yes, welcome your sample order before bulk order.We will send the sample directly to your door by express.The quality of sample will prove our ability
6.What is MOQ
Usually our Minimum order quantity is 10g.
Details
Flibanserin
Flibanserin structure
|
Common Name | Flibanserin | ||
---|---|---|---|---|
CAS Number | 167933-07-5 | Molecular Weight | 390.40200 | |
Density | 1.292 g/cm3 | Boiling Point | N/A | |
Molecular Formula | C20H21F3N4O | Melting Point | N/A | |
MSDS | ChineseUSA | Flash Point | N/A | |
Symbol |
GHS06 |
Signal Word | Danger |
Use of Flibanserin
Flibanserin is a novel multifunctional serotonin agonist and antagonist (MSAA) that improves sexual functioning in premenopausal women who suffer from reduced sexual interest and desire.IC50 value:Target: serotoninin vivo: The multifunctional serotonergic agent Flibanserin is both a serotonin 1A agonist and a serotonin 2A antagonist. Flibanserin theoretically improves sexual functioning by enhancing downstream release of dopamine and norepinephrine while reducing serotonin release in the brain circuits that mediate symptoms of reduced sexual interest and desire. Flibanserin, a new molecular entity for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. Flibanserin improves interest in and desire for sex by hypothetically targeting these circuits and causing the release of dopamine and norepinephrine while also reducing the release of serotonin. Flibanserin has demonstrated clinical efficacy in premenopausal women who have reduced interest in and desire for sex and has 2 principal pharmacologic actions in microcircuits: it is a full agonist at postsynaptic serotonin 5HT1A receptors and an antagonist at postsynaptic 5HT2A receptors.